Relationship among lymphocytes, free/total prostate specific antigen, lower urinary tract symptoms and prostatic inflammation in benign prostatic hyperplasia patients

Relationship among lymphocytes, free/total prostate specific antigen, lower urinary tract symptoms and prostatic inflammation in benign prostatic hyperplasia patients

Bibliographic Details
Main Authors:	Haonan Zhang, Lanpeng Lu, Shun Wan, Zhiping Wang
Format:	Article
Language:	English
Published:	Elsevier 2021-06-01
Series:	Asian Journal of Surgery
Subjects:	BPH f/t PSA Lymphocytes Prostatic inflammation LUTS
Online Access:	http://www.sciencedirect.com/science/article/pii/S1015958421002128

Similar Items

An Approach to the Management of Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia.
by: David Bouhadana, et al.
Published: (2021-07-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-08-01)

Molecular Detection of Prostate Specific Antigen in Patients with Prostate Cancer or Benign Prostate Hyperplasia the First Investigation from Iran
by: L Andonian, et al.
Published: (2005-09-01)

Prostate – Specific Antigen (Psa) as a Screening Tool for Benign Prostate Hyperplasia (Bph) and Prostate Cancer (Pca) in Sulaimani Province
by: Sirwan M. Muhammad, et al.
Published: (2013-09-01)

Comparative analysis of resected prostate weight in diabetic and non-diabetic benign prostatic hyperplasia patients
by: Emadouddin Moudi, et al.
Published: (2017-02-01)

The Current Approaches of Urologist in Treatment of Benign Prostate Hyperplasia in Turke
by: Furkan SENDOGAN, et al.
Published: (2019-06-01)

Effect of urinary retention on the levels of prostate specific antigen (PSA) and prostatic acid phosphatase (PAP) in prostatic disease
by: R Chawla, et al.
Published: (2003-01-01)

The role of Cucurbita pepo in the management of patients affected by lower urinary tract symptoms due to benign prostatic hyperplasia: A narrative review
by: Rocco Damiano, et al.
Published: (2016-07-01)

The effectiveness of tamsulosin in Benign Prostate Hyperplasia (BPH) patients with Lower Urinary Tract Symptoms (LUTS): a multi-centre cohort retrospective study
by: Ida Bagus Putra Pramana, et al.
Published: (2020-03-01)

Prostate-specific antigen reduction after empiric antibiotic treatment does not rule out biopsy in patients with lower urinary tract symptoms: prospective, controlled, single-center study
by: Hasan Anıl Atalay, et al.
Published: (2017-06-01)

Safety and efficacy of silodosin for the treatment of benign prostatic hyperplasia
by: Yoshida M, et al.
Published: (2011-06-01)

Correlation between testosterone level, serum prostate-specific antigen level, and diabetes mellitus with grade inflammation of the prostate
by: A.A G.A. Anom A Wiradana, et al.
Published: (2019-06-01)

Efficacy and safety of doxazosin (Cardura TM ) in the management of Benign Prostatic Hyperplasia
by: E A Jeje, et al.
Published: (2011-01-01)

Estimation of Testosterone, Estradiol and some Markers in Sera of Iraqi Patients with Benign Prostatic Hyperplasia.
by: Baghdad Science Journal
Published: (2013-12-01)

High Serum Prostate Specific Antigen as A Risk Factor for Moderate-Severe Prostate Inflammation in Patient with Benign Prostatic Hyperplasia
by: Gede Wirya K Duarsa, et al.
Published: (2015-12-01)

High Serum Prostate Specific Antigen as A Risk Factor for Moderate-Severe Prostate Inflammation in Patient with Benign Prostatic Hyperplasia
by: Gede Wirya K Duarsa, et al.
Published: (2015-12-01)

Giant Benign Prostatic Hyperplasia in a Pakistani Patient
by: Zafaruddin Khan, et al.
Published: (2014-01-01)

Comparative evaluation of naftopidil and tamsulosin in the treatment of patients with lower urinary tract symptoms with benign prostatic hyperplasia
by: Mahavir Singh Griwan, et al.
Published: (2014-01-01)

RELATION OF TOTAL CHOLESTEROL TO PROSTATE VOLUME AND INTRAVESICAL PROSTATIC PROTRUSION IN BENIGN PROSTATIC HYPERPLASIA PATIENTS
by: Made Devi Desyana Arisandi, et al.
Published: (2021-07-01)

Bladder drainage and glandular epithelial morphometry of the prostate in benign prostatic hyperplasia with severe symptoms
by: Carlos A. Cury, et al.
Published: (2006-04-01)

Intravescical prostatic protrusion is a predictor of alpha blockers response: results from an observational study
by: L. Topazio, et al.
Published: (2018-02-01)

Diffusion-weighted MR imaging and ADC measurement in normal prostate, benign prostatic hyperplasia and prostate carcinoma
by: Sally Emad-Eldin, et al.
Published: (2014-06-01)

Prevalence of clinical benign prostatic hyperplasia amongst community-dwelling men in a South-Western Nigerian rural setting: A cross-sectional study
by: R.W. Ojewola, et al.
Published: (2017-06-01)

Prostatic artery embolization versus transurethral resection of the prostate in management of benign prostatic hyperplasia
by: Ahmed Radwan, et al.
Published: (2020-09-01)

Association Between Prostate Zonal Volume and Erectile Dysfunction in Patients With Benign Prostatic Hyperplasia
by: Muhammed M. Qalawena, MD, et al.
Published: (2020-06-01)

Incidental Prostate Cancer in Patients Treated for Benign Prostate Hyperplasia in the Period of 21 Years
by: Ivan Pezelj, et al.
Published: (2018-01-01)

Daidzein plus isolase associated with zinc improves clinical symptoms and quality of life in patients with LUTS due to benign prostatic hyperplasia: Results from a phase I-II study
by: Daniele Tiscione, et al.
Published: (2017-03-01)

Efficacy and safety of transurethral split of prostate for benign prostatic hyperplasia: a meta-analysis
by: Yiyu Huang, et al.
Published: (2020-09-01)

Bladder stone secondary to prostatic urethral lift (PUL) for benign prostatic hyperplasia (BPH)
by: JiHun Kang
Published: (2021-11-01)

Sexual Dysfunctions Related to Drugs Used in the Management of Lower Urinary Tract Symptoms Due to Benign Prostatic Hyperplasia: A Narrative Review on α-Blockers and 5-Alpha Reductase Inhibitors
by: Antonio La Torre, et al.
Published: (2021-07-01)

Experience of terahertz therapy in benign prostatic hyperplasia combined with chronic abacterial prostatitis
by: Popkov V.M., et al.
Published: (2014-12-01)

Prostatic urethral lift (UroLift): a real-world analysis of outcomes using hospital episodes statistics
by: Toby Page, et al.
Published: (2021-04-01)

Influence of chronic ischemic disorders in the prostate on the development of benign prostatic hyperplasia
by: G. E. Roitberg, et al.
Published: (2020-06-01)

The impact of prostate-transurethral resection on erectile dysfunction in benign prostatic hyperplasia
by: Oka AAG, et al.
Published: (2019-04-01)

Comparison of the rate of complications after TUEB and cystic prostatectomy in patients with benign prostatic hyperplasia
by: G. V. Bachurin
Published: (2013-08-01)

The impact of adding solifenacin to tamsulosin therapy for treatment of storage lower urinary tract symptoms owing to benign prostatic hyperplasia
by: Mohamed Elbadry, et al.
Published: (2020-12-01)

Multicenter, prospective, comparative cohort study evaluating the efficacy and safety of alfuzosin 10 mg with regard to blood pressure in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia with or without antihypertensive med
by: Zhang LT, et al.
Published: (2015-01-01)

Genetic alterations in benign prostatic hyperplasia patients
by: Mohamed, Hanaa Mahmoud, et al.
Published: (2017-11-01)

Detection of Polyomaviral Large T Antigen in Benign Prostatic Hyperplasia and Prostate Carcinoma Tissues
by: Sina Arabshahi
Published: (2015-01-01)

PERBEDAAN IPSS, Q MAX, DAN VOLUME PROSTAT PADA PEMBERIAN KOMBINASI INHIBITOR 5α-REDUKTASE (DUTASTERIDE) DAN ANTI ESTROGEN (TAMOXIFEN) PADA PASIEN BPH YANG MENGALAMI LUTS TANPA KOMPLIKASI
by: Kurnia Penta Seputra, et al.
Published: (2016-12-01)

Cannot write session to /tmp/vufind_sessions/sess_hh4mvbhq1bfu5kbpflo0cr2m4n